Home
>
National Drug Code (NDC)
>
DICLOFENAC SODIUM
DICLOFENAC SODIUM - 0228-2717-11 - (diclofenac sodium)
Drug Information of DICLOFENAC SODIUM
| Product NDC: | 0228-2717 |
| Proprietary Name: | DICLOFENAC SODIUM |
| Non Proprietary Name: | diclofenac sodium |
| Active Ingredient(s): | 100 mg/1 & nbsp; diclofenac sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DICLOFENAC SODIUM
| Product NDC: | 0228-2717 |
| Labeler Name: | Actavis Elizabeth LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075910 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020109 |
Package Information of DICLOFENAC SODIUM
| Package NDC: | 0228-2717-11 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-2717-11) |
NDC Information of DICLOFENAC SODIUM
| NDC Code | 0228-2717-11 |
| Proprietary Name | DICLOFENAC SODIUM |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-2717-11) |
| Product NDC | 0228-2717 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac sodium |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20020109 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Elizabeth LLC |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
